AIMS: To examine the effects of salbutamol and L-arginine, two compounds acting largely on the endothelium, and the endothelium-independent agent nitroglycerin on blood pressure, arterial compliance, cardiac function and vascular resistance. METHODS: Continuous radial pulse wave analysis, whole-body impedance cardiography, and plethysmographic blood pressure from fingers in the supine position and during head-up tilt were recorded in nine healthy subjects. Data were captured before and after L-arginine (10 mg mg(-1) min(-1)) or saline infusion, salbutamol (400 microg) or placebo inhalation, and sublingual nitroglycerin (0.25 mg) or placebo resoriblet. RESULTS: The results of all measurements were comparable before drug administration. The effects of inhaled salbutamol were apparent in the supine position: systemic vascular resistance (-9.2 +/- 2.6%) and augmentation index (-4.0 +/- 1.5%) decreased, and heart rate (8.6 +/- 2.5%) and cardiac output (8.8 +/- 3.1%) increased. L-arginine had no clear effects on supine haemodynamics, but during head-up tilt blood pressure was moderately decreased and reduction in aortic reflection time prevented, indicating improved large arterial compliance. Nitroglycerin reduced supine vascular resistance (-6.7 +/- 1.8%) and augmentation index (-7.4 +/- 1.6%), and increased cardiac output (+9.2 +/- 2.7%). During head-up tilt, nitroglycerin increased cardiac output (+10.6 +/- 5.6%) and heart rate (+40 +/- 7.5%), decreased vascular resistance (-7.8 +/- 5.8%) and augmentation index (-18.7 +/- 3.2%), and prevented the decrease in aortic reflection time. CONCLUSIONS:Inhaled salbutamol predominantly changed supine haemodynamics, whereas the moderate effects of L-arginine were observed during the head-up tilt. In contrast, small doses of nitroglycerin induced major changes in haemodynamics both supine and during the head-up tilt. Altogether, these results emphasize the importance of haemodynamic measurements in both the supine and upright positions.
RCT Entities:
AIMS: To examine the effects of salbutamol and L-arginine, two compounds acting largely on the endothelium, and the endothelium-independent agent nitroglycerin on blood pressure, arterial compliance, cardiac function and vascular resistance. METHODS: Continuous radial pulse wave analysis, whole-body impedance cardiography, and plethysmographic blood pressure from fingers in the supine position and during head-up tilt were recorded in nine healthy subjects. Data were captured before and after L-arginine (10 mg mg(-1) min(-1)) or saline infusion, salbutamol (400 microg) or placebo inhalation, and sublingual nitroglycerin (0.25 mg) or placebo resoriblet. RESULTS: The results of all measurements were comparable before drug administration. The effects of inhaled salbutamol were apparent in the supine position: systemic vascular resistance (-9.2 +/- 2.6%) and augmentation index (-4.0 +/- 1.5%) decreased, and heart rate (8.6 +/- 2.5%) and cardiac output (8.8 +/- 3.1%) increased. L-arginine had no clear effects on supine haemodynamics, but during head-up tilt blood pressure was moderately decreased and reduction in aortic reflection time prevented, indicating improved large arterial compliance. Nitroglycerin reduced supine vascular resistance (-6.7 +/- 1.8%) and augmentation index (-7.4 +/- 1.6%), and increased cardiac output (+9.2 +/- 2.7%). During head-up tilt, nitroglycerin increased cardiac output (+10.6 +/- 5.6%) and heart rate (+40 +/- 7.5%), decreased vascular resistance (-7.8 +/- 5.8%) and augmentation index (-18.7 +/- 3.2%), and prevented the decrease in aortic reflection time. CONCLUSIONS: Inhaled salbutamol predominantly changed supine haemodynamics, whereas the moderate effects of L-arginine were observed during the head-up tilt. In contrast, small doses of nitroglycerin induced major changes in haemodynamics both supine and during the head-up tilt. Altogether, these results emphasize the importance of haemodynamic measurements in both the supine and upright positions.
Authors: L Lehtimäki; H Kankaanranta; S Saarelainen; P Hahtola; R Järvenpää; T Koivula; V Turjanmaa; E Moilanen Journal: Am J Respir Crit Care Med Date: 2001-06 Impact factor: 21.405
Authors: Ian B Wilkinson; Ian R Hall; Helen MacCallum; Isla S Mackenzie; Carmel M McEniery; Bart J van der Arend; Yae-Eun Shu; Laura S MacKay; David J Webb; John R Cockcroft Journal: Arterioscler Thromb Vasc Biol Date: 2002-01 Impact factor: 8.311
Authors: H Sumino; T Nakamura; T Kanda; K Sato; T Sakamaki; T Takahashi; Y Saito; J Hoshino; T Kurashina; R Nagai Journal: Hypertension Date: 2000-12 Impact factor: 10.190
Authors: M Giulia Gagliardi; F Crea; B Polletta; C Bassano; G La Vigna; L Ballerini; P Ragonese Journal: Eur Heart J Date: 2001-02 Impact factor: 29.983
Authors: Elina J Hautaniemi; Antti J Tikkakoski; Arttu Eräranta; Mika Kähönen; Esa Hämäläinen; Ursula Turpeinen; Heini Huhtala; Jukka Mustonen; Ilkka H Pörsti Journal: PLoS One Date: 2019-10-18 Impact factor: 3.240
Authors: Peter H Charlton; Birutė Paliakaitė; Kristjan Pilt; Martin Bachler; Serena Zanelli; Dániel Kulin; John Allen; Magid Hallab; Elisabetta Bianchini; Christopher C Mayer; Dimitrios Terentes-Printzios; Verena Dittrich; Bernhard Hametner; Dave Veerasingam; Dejan Žikić; Vaidotas Marozas Journal: Am J Physiol Heart Circ Physiol Date: 2021-12-24 Impact factor: 4.733